Givbux Inc (GBUX) Stock Analysis

Verdict: AVOID

Severe liquidity crisis and accelerating losses suggest imminent insolvency; GBUX is a 'zombie' microcap with no viable path to recovery.

Investment score: 2/100

Analysis as of

Is Givbux Inc stock worth reviewing? The TradeMates thesis

GBUX displays all hallmarks of a terminal microcap: negative equity (-$4.9M), microscopic liquidity, and a business model that loses $13 for every dollar earned.

7-factor investment score

Givbux Inc opportunities and risks

What speaks for GBUX

What speaks against GBUX

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
GBUXn/a0.2xn/a31.0%-1353.1%-1644.5%
XBP0.0x0.0x0.3x18.5%167.8%-639.9%
APCXn/a4.0xn/a56.7%-325.9%-37.6%
PBIT.CNn/a0.9x2683.9x82.6%-12.6%20.2%
OLBn/a0.1x0.2x-27.5%-73.2%-265.3%
ZPASn/a0.2xn/a23.7%-2141.8%-425.6%
Peer mediann/a0.2x0.2x23.7%-73.2%-265.3%

Frequently asked questions about Givbux Inc (GBUX)

Is GBUX stock a good investment?

The TradeMates model rates Givbux Inc as AVOID with an investment score of 2/100. GBUX displays all hallmarks of a terminal microcap: negative equity (-$4.9M), microscopic liquidity, and a business model that loses $13 for every dollar earned. This is algorithmic model output, not personal investment advice.

Is GBUX stock a buy?

The TradeMates model verdict for GBUX is AVOID with an investment score of 2/100. Treat this as a model signal to review, not a personal buy recommendation.